KAM
Krensavage Asset Management Portfolio holdings
AUM
$189M
This Quarter Return
-1.53%
1 Year Return
+19.71%
3 Year Return
+56.44%
5 Year Return
+120.01%
10 Year Return
+215.64%
AUM
$310M
AUM Growth
+$310M
(+11%)
Cap. Flow
+$36.9M
Cap. Flow
% of AUM
11.89%
Top 10 Holdings %
Top 10 Hldgs %
90.45%
Holding
17
New
1
Increased
10
Reduced
4
Closed
2
Top Buys
1 |
SCMP
Sucampo Pharmaceuticals, Inc.
SCMP
|
$10.3M |
2 |
Merck
MRK
|
$8.38M |
3 |
Gilead Sciences
GILD
|
$7.95M |
4 |
Orthofix Medical
OFIX
|
$1.98M |
5 |
Enanta Pharmaceuticals
ENTA
|
$1.32M |
Top Sells
1 |
Amgen
AMGN
|
$9.7M |
2 |
United Therapeutics
UTHR
|
$4.9M |
3 |
DSCI
Derma Sciences, Inc. Common Stock (DE)
DSCI
|
$4.63M |
4 |
STRR
Star Equity Holdings
STRR
|
$807K |
5 |
JNP
Juniper Pharmaceuticals, Inc. Common Stock
JNP
|
$227K |
Sector Composition
1 | Healthcare | 72.53% |